IKBKB and atherosclerosis: Since inhibition of NF-κB activity in endothelia cells also decreased vascular inflammation and atherosclerosis in ApoE−/− mice (14), these studies suggest that inhibiting IKKβ/NF-κB signaling in the vasculature has anti-atherogenic effects.